Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

July 3, 2018

Barclay Damon Launches Cannabis Team

July 3, 2018—Barclay Damon announces today the official launch of the law firm's cannabis team, led by attorney Sara Payne, a member of the New York State Bar Association Committee on Cannabis Law.

The members of Barclay Damon's multidisciplinary team, which represents individuals and organizations participating in or impacted by legal cannabis operations, have nearly a decade of cannabis-specific experience. Coupled with Barclay Damon's long history of successfully representing businesses in highly regulated fields, the firm is well qualified to counsel clients across the full spectrum of cannabis-related legal issues.

Payne said, "We are proud to represent clients in this dynamic and rapidly changing area of law, whether they are entrepreneurs, established companies, or individuals with cannabis-based business interests. Our team's bench depth allows us to carefully monitor developments in legislation and marketplace trends to help them adapt and succeed in the changing landscape."

"As an attorney with established clients in this field," Payne continued, "I feel fortunate to be part of a firm with such an extensive range of resources and industry knowledge in the area."

Payne represented one of the original five registered organizations authorized to produce and distribute medical marijuana in New York State and has assisted the company since its inception with all aspects of its operations. She is a contributing editor for Cannabis Law Digest, and her recent presentations include "Legislative Developments in Medical Marijuana and Industrial Hemp in New York," a New York State Bar Association continuing legal education (CLE) seminar presented in May.

John Langan, Barclay Damon's managing partner, said, "Our firm prides itself on the spirit of innovation that drives us, and we are delighted to be an integral part of our cannabis clients' operations and growth as they navigate this new regulatory terrain and emerging business environment. We are excited to see what lies ahead for these clients and honored to partner with them to help minimize their risks and support their endeavors."

Barclay Damon currently has approximately 10 clients with businesses based in this evolving field. In addition to representing cannabis-based businesses, the team's understanding of how cannabis laws and regulations intersect with mainstream organizations and individual rights is critical to numerous additional clients.

Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients' businesses. With 275 attorneys, Barclay Damon is a leading regional law firm that operates from a strategic platform of offices located in the Northeastern United States and Toronto.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

The New York FY 2025 Budget – CDPAP FIs Under Threat

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Anderson, Beauchamp, Murray, Angeles, Monegro, and Bullock—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Updated Bulletin on Tracking Technologies in the Health Care Industry

Alerts

NYS Board of Regents Adopts Regulations on the Mental Health Diagnostic Privilege

Alerts

First Department Clarifies Pleading Requirements Under NYS Child Victims Act

Alerts

Beneficial Ownership Reporting Requirements Under the CTA: Quarterly Reminder

We're Growing in DC!

We’re excited to announce Barclay Damon’s combination with Washington DC–based Shapiro, Lifschitz & Schram. SLS’s 10 lawyers, three paralegals, and four administrative staff will join Barclay Damon while maintaining their current office in DC’s central business district. Our clients will benefit from SLS’s corporate, real estate, finance, and construction litigation experience and national energy-industry profile, and their clients from our full range of services.

Read More

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out